Original language | English |
---|---|
Pages (from-to) | e430-e431 |
Journal | The Lancet Oncology |
Volume | 18 |
Issue number | 8 |
DOIs | |
Publication status | Published - 1 Aug 2017 |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Evidence-based management of adult patients with diffuse glioma – Authors' reply. / Weller, Michael; van den Bent, Martin; Tonn, Jörg C.; Stupp, Roger; Preusser, Matthias; Cohen-Jonathan-Moyal, Elizabeth; Henriksson, Roger; Rhun, Emilie Le; Balana, Carmen; Chinot, Olivier; Bendszus, Martin; Reijneveld, Jaap C.; Dhermain, Frederic; French, Pim; Marosi, Christine; Watts, Colin; Oberg, Ingela; Pilkington, Geoffrey; Baumert, Brigitta G.; Taphoorn, Martin J.B.; Hegi, Monika; Westphal, Manfred; Reifenberger, Guido; Soffietti, Riccardo; Wick, Wolfgang; the European Association for Neuro-Oncology (EANO) Task Force on Gliomas.
In: The Lancet Oncology, Vol. 18, No. 8, 01.08.2017, p. e430-e431.Research output: Contribution to journal › Letter › Academic › peer-review
TY - JOUR
T1 - Evidence-based management of adult patients with diffuse glioma – Authors' reply
AU - Weller, Michael
AU - van den Bent, Martin
AU - Tonn, Jörg C.
AU - Stupp, Roger
AU - Preusser, Matthias
AU - Cohen-Jonathan-Moyal, Elizabeth
AU - Henriksson, Roger
AU - Rhun, Emilie Le
AU - Balana, Carmen
AU - Chinot, Olivier
AU - Bendszus, Martin
AU - Reijneveld, Jaap C.
AU - Dhermain, Frederic
AU - French, Pim
AU - Marosi, Christine
AU - Watts, Colin
AU - Oberg, Ingela
AU - Pilkington, Geoffrey
AU - Baumert, Brigitta G.
AU - Taphoorn, Martin J.B.
AU - Hegi, Monika
AU - Westphal, Manfred
AU - Reifenberger, Guido
AU - Soffietti, Riccardo
AU - Wick, Wolfgang
AU - the European Association for Neuro-Oncology (EANO) Task Force on Gliomas
PY - 2017/8/1
Y1 - 2017/8/1
UR - http://www.scopus.com/inward/record.url?scp=85025836494&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(17)30515-6
DO - 10.1016/S1470-2045(17)30515-6
M3 - Letter
AN - SCOPUS:85025836494
VL - 18
SP - e430-e431
JO - Lancet Oncology
JF - Lancet Oncology
SN - 1470-2045
IS - 8
ER -